Pyxis Oncology: HC Wainwright Raises PT to $7, Maintains Buy Rating

Tuesday, Mar 24, 2026 7:16 am ET1min read
PYXS--

Pyxis Oncology: HC Wainwright Raises PT to $7, Maintains Buy Rating

Pyxis Oncology: HC Wainwright Raises PT to $7, Maintains Buy Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet